AzTrials
AzTrials

Out-Of-Hospital Cardiac ArrestFEICANCT06072092

Frontal EEG in OHCA Feasibility Study

An observational study of Out-Of-Hospital Cardiac Arrest and BIS, run by Medical University of Graz at 1 site in Austria.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study aims to optimize the treatment of out-of-hospital cardiac arrest (OHCA) by focusing on neurological outcomes through Bispectral Index (BIS) monitoring. It will evaluate the feasibility of BIS monitoring in the prehospital phase, assess the need for sedation based on BIS values, and examine the timing of… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Out-Of-Hospital Cardiac Arrest, BIS
What is being tested?
BIS Monitor
Type of treatment
Medical device
How many people
45 participants
Where
1 siteAustria
Study dates
1 Jan 2024to 30 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Out-of-hospital cardiac arrest adult patients

Who may be able to join

  • Age ≥18 years
  • In out-of-hospital cardiac arrest (OHCA)

Who cannot join

  • BIS application non-possible (for example, due to massive facial trauma)
  • No ALS (Advanced Life Support) performed
  • Clear signs of death
  • Sustained ROSC (>5 minutes after CPR with signs of life) on the arrival of the emergency physician

Trial locations and contacts

1 site in 1 country.

Austria1 site
  • Medical University Graz

    Graz, Styria, 8036

Other trials in Austria

About this study

Official title: Frontal EEG in Out-of-hospital Cardiac Arrest - a Prospective Observational Feasibility Study

This study aims to optimize the treatment of out-of-hospital cardiac arrest (OHCA) by focusing on neurological outcomes through Bispectral Index (BIS) monitoring. It will evaluate the feasibility of BIS monitoring in the prehospital phase, assess the need for sedation based on BIS values, and examine the timing of interventions in ICU (intensive care unit) settings to identify irreversible Hypoxic-Ischemic Brain Injury (HIBI).

Read the detailed description

The research project is designed to contribute to the low survival discharge rates of OHCA patients in Europe, which is currently around 8%.

Objectives:

  1. To assess the feasibility of BIS monitoring in the prehospital environment during CPR and ROSC.
  2. To determine the optimal mean BIS cut-off value after ROSC (Return of Spontaneous Circulation) during the prehospital phase.
  3. To assess BIS and etCO2 values in OHCA patients under evaluation of CPR quality.
  4. To understand the sedation needs based on BIS values.
  5. To identify the timing of interventions in the ICU that signify irreversible HIBI.

Phases:

  • Phase 1: The initial focus is assessing BIS and etCO2 values in OHCA patients receiving CPR.
  • Phase 2: We will investigate whether patients with higher mean BIS values (>25) require earlier and more sedation than those with lower BIS values.
  • Phase 3: This phase will examine ICU interventions and their timing to ascertain which patients are at risk of suffering from irreversible HIBI.

Methodology:

The project will utilize prehospital and ICU settings for a multidisciplinary approach, integrating cardiological, neurological, and anesthesiological perspectives. A pilot phase of 5 patients will be conducted initially to fine-tune the protocol and address any technical issues with the equipment.

Timeline:

The study will span approximately 14 months, starting with patient recruitment, data collection, and analysis and ending with the publication of results.

This project aims to provide critical insights into the feasibility and effectiveness of BIS monitoring in improving neurological outcomes for OHCA patients.

Being tested
BIS Monitor
Keywords
OHCA, BIS, ROSC, prehospital, PRU
Medical subject headings
Out-of-Hospital Cardiac Arrest

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • BIS MonitorDevice

    No interventions will be administered, but in addition to the standard of care according to the Guidelines of the European Resuscitation Council 2021, a frontal EEG-monitoring (BIS), a CPRMeter and a FlowMeter will be installed. The study will be observational only; the readings of the BIS monitor will be blinded to the treating PRU team.

Study groups in NCT06072092
Study groupRoleWhat they receive
Out-of-hospital cardiac arrest adult patientsAll patients aged ≥18 years and in out-of-hospital cardiac arrest (OHCA) on arrival at the physician response unit (PRU) in Graz, Austria + surroundings.
Receives: Device: BIS Monitor

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility of BIS prehospital via quality parameters.

    To evaluate if frontal EEG (BIS) measurements are feasible and valid under CPR and at ROSC in the prehospital setting. The proportion of patients meeting the signal quality criteria in more than 75% of the measurement period (Signal quality index >75, Electromyogram <30) will be presented with a two-sided 95% confidence interval to assess the primary aim.

    Measured: From PRU arrival until hand-over to the hospital (prehospital phase), on average 60 minutes.

  2. Feasibility of BIS prehospital via a questionnaire.

    The prehospital BIS feasibility will be assessed with a short questionnaire about the application and its handling.

    Measured: Prehospital phase, on average 60 minutes.

Secondary outcomes (4)
  1. Prediction of neurological outcome.

    To find the optimal mean BIS cut-off after ROSC throughout the prehospital phase associated with higher CPC scores at 1 month after the event.

    Measured: Prehospital phase, on average 60 minutes.

  2. CPR quality

    To assess the correlation of BIS and etCO2 values in OHCA patients receiving CPR under evaluation of CPR quality.

    Measured: Prehospital phase, on average 30 minutes.

  3. Sedation at ROSC

    Patients with higher mean BIS values (>25) will require earlier and more sedation than patients with values below.

    Measured: Prehospital phase, on average 30 minutes.

  4. ICU care

    To assess all timings of interventions on ICU indicating irreversible HIBI.

    Measured: ICU stay, on average 4 days.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2023
  2. Study start1 Jan 2024
  3. Primary completion23 Apr 2025
  4. Study completion30 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06072092
Sponsor's protocol ID
V2.7.1
Acronym
FEICA
Status last verified
Aug 2026
First submitted
2 Oct 2023
Last updated
12 Aug 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: Anonymized data will be made available on specific requests.

Publications

  • Grasner JT, Wnent J, Herlitz J, Perkins GD, Lefering R, Tjelmeland I, Koster RW, Masterson S, Rossell-Ortiz F, Maurer H, Bottiger BW, Moertl M, Mols P, Alihodzic H, Hadzibegovic I, Ioannides M, Truhlar A, Wissenberg M, Salo A, Escutnaire J, Nikolaou N, Nagy E, Jonsson BS, Wright P, Semeraro F, Clarens C, Beesems S, Cebula G, Correia VH, Cimpoesu D, Raffay V, Trenkler S, Markota A, Stromsoe A, Burkart R, Booth S, Bossaert L. Survival after out-of-hospital cardiac arrest in Europe - Results of the EuReCa TWO study. Resuscitation. 2020 Mar 1;148:218-226. doi: 10.1016/j.resuscitation.2019.12.042. Epub 2020 Feb 3.

    PubMed 32027980
  • Sandroni C, Skrifvars MB, Taccone FS. Brain monitoring after cardiac arrest. Curr Opin Crit Care. 2023 Apr 1;29(2):68-74. doi: 10.1097/MCC.0000000000001023. Epub 2023 Feb 16.

    PubMed 36762679
  • Chang CY, Chen CS, Chien YJ, Lin PC, Wu MY. The Effects of Early Bispectral Index to Predict Poor Neurological Function in Cardiac Arrest Patients: A Systematic Review and Meta-Analysis. Diagnostics (Basel). 2020 Apr 30;10(5):271. doi: 10.3390/diagnostics10050271.

    PubMed 32365854
  • Arbas-Redondo E, Rosillo-Rodriguez SO, Merino-Argos C, Marco-Clement I, Rodriguez-Sotelo L, Martinez-Marin LA, Martin-Polo L, Velez-Salas A, Caro-Codon J, Garcia-Arribas D, Armada-Romero E, Lopez-De-Sa E. Bispectral index and suppression ratio after cardiac arrest: are they useful as bedside tools for rational treatment escalation plans? Rev Esp Cardiol (Engl Ed). 2022 Dec;75(12):992-1000. doi: 10.1016/j.rec.2022.03.004. Epub 2022 May 12. English, Spanish.

    PubMed 35570124
  • Eichinger M, Zoidl P, Reisinger AC, Orlob S, Hatzl S, Eichlseder M, Pichler A, Eberl A, Kuenzer T, Zajic P, Heuschneider L, Honnef G, Rief M, Bornemann-Cimenti H. Assessment of frontal EEG measurement in out-of-hospital cardiac arrest: a prospective observational feasibility study - study protocol. BMJ Open. 2025 Feb 26;15(2):e094258. doi: 10.1136/bmjopen-2024-094258.

    PubMed 40010837

Questions about this trial

What is this clinical trial studying?

An observational study of Out-Of-Hospital Cardiac Arrest and BIS, run by Medical University of Graz at 1 site in Austria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 12 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Austria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility of BIS prehospital via quality parameters. (time frame: From PRU arrival until hand-over to the hospital (prehospital phase), on average 60 minutes.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06072092, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Aug 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in